Cervical cancer elimination in India: Repurposing diagnostics, vaccination, and accelerating policy for the 2030 target
Cancer · 2026
DOI: 10.1002/cncr.70292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2026. Verfasst von Vaibhav K Tamrakar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Papillomavirus Vaccines, Disease Eradication. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Cervical cancer remains one of the most significant yet preventable causes of cancer‐related mortality among women in India. Current estimates indicate that the country reports approximately 127,000 new cases and nearly 80,000 deaths annually, accounting for about one fifth of the global burden. Despite advances in vaccination, screening, and molecular diagnostics, coverage remains critically low: fewer than 2% of women undergo screening, and less than 1% have received a human papillomavirus (HPV) vaccine. The introduction of the indigenous quadrivalent vaccine Cervavac in 2023 has provided renewed momentum; however, limitations in infrastructure, public awareness, and stratic barrier to implementation continue to hinder progress toward achieving the World Health Organization's 2030 elimination targets. This opinion article highlights the epidemiological landscape, diagnostic and programmatic barriers, and emphasis to repurpose India's vast coronavirus disease‐era reverse transcriptase‐polymerase chain reaction network for HPV molecular testing. Integrating HPV vaccination into the Universal Immunization Program and incorporating the HPV Nucleic Acid Amplification Test (NAAT) into the National Essential Diagnostics List (NEDL) are critical steps for accelerating India's pathway to cervical cancer elimination by 2030.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
- Department of Microbiology, State-Level Virus Research and Diagnostic Laboratory, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
ORCID-Profile: Vaibhav K Tamrakar
Förderung
- Indian Council of Medical Research
Zitieren
APA
Tamrakar, V. K., Sharma, K., Singh, P., Bhargava, A., & Negi, S. S. (2026). Cervical cancer elimination in India: Repurposing diagnostics, vaccination, and accelerating policy for the 2030 target. Cancer. https://doi.org/10.1002/cncr.70292
Vancouver
Tamrakar VK, Sharma K, Singh P, Bhargava A, Negi SS. Cervical cancer elimination in India: Repurposing diagnostics, vaccination, and accelerating policy for the 2030 target. Cancer. 2026. doi:10.1002/cncr.70292
BibTeX
@article{Tamrakar2026,
author = {Tamrakar, Vaibhav K and Sharma, Kuldeep and Singh, Pushpendra and Bhargava, Anudita and Negi, Sanjay Singh},
title = {Cervical cancer elimination in India: Repurposing diagnostics, vaccination, and accelerating policy for the 2030 target},
journal = {Cancer},
year = {2026},
doi = {10.1002/cncr.70292}
}
EUVIMED